RhoE promotes metastasis in gastric cancer through a mechanism dependent on enhanced expression of CXCR4

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Feng, Bin ^a   Li, Kai ^a   Zhong, Haixing ^a   Ren, Gui ^a   Wang, Hefei ^a   Shang, Yulong ^a   Bai, Ming ^a   Liang, Jie ^a   Wang, Xin ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RHO FACTOR; RHOE PROTEIN; UNCLASSIFIED DRUG; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RND3 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; DOWNSTREAM PROCESSING; ENZYME INDUCTION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; CANCER STAGING; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, CXCR4; RHO GTP-BINDING PROTEINS; STOMACH NEOPLASMS;

EID: 84896718887     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081709     Document Type: Article

References (29)

1. Alberts SR, Cervantes A, van de Velde CJ (2003) Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14 Suppl 2: ii31-ii36. PubMed: 12810455. (Pubitemid 36874136)
2. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009) Gastric cancer. Lancet 374: 477-490. doi:10.1016/S0140-6736(09)60617-6. PubMed: 19625077.
3. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428. doi:10.1172/JCI39104. PubMed: 19487818.
4. Villalonga P, Guasch RM, Riento K, Ridley AJ (2004) RhoE inhibits cell cycle progression and Ras-induced transformation. Mol Cell Biol 24: 7829-7840. doi:10.1128/MCB.24.18.7829-7840.2004. PubMed: 15340047. (Pubitemid 39167435)
5. Guasch RM, Scambler P, Jones GE, Ridley AJ (1998) RhoE regulates actin cytoskeleton organization and cell migration. Mol Cell Biol 18: 4761-4771. PubMed: 9671486. (Pubitemid 28343061)
6. Foster R, Hu KQ, Lu Y, Nolan KM, Thissen J et al. (1996) Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation. Mol Cell Biol 16: 2689-2699. PubMed: 8649376. (Pubitemid 26161272)
7. Zhou J, Yang J, Li K, Mo P, Feng B et al. (2013) RhoE is Associated with Relapse and Prognosis of Patients with Colorectal. Cancer - Ann Surg Oncol 20: 175-182. doi:10.1245/s10434-012-2472-6.
8. Zhao H, Yang J, Fan T, Li S, Ren X (2012) RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway. Tumour Biol 33: 1363-1374. doi:10.1007/s13277-012-0384-5. PubMed: 22477709.
9. Ma W, Wong CC, Tung EK, Wong CM, Ng IO (2012) RhoE is frequently downregulated in HCC and suppresses HCC invasion through antagonizing the Rho/ROCK/MYPT pathway. Hepatology.
10. Klein RM, Aplin AE (2009) Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions. Cancer Res 69: 2224-2233. doi:10.1158/0008-5472.CAN-08-3201. PubMed: 19244113.
11. Grise F, Sena S, Bidaud-Meynard A, Baud J, Hiriart JB et al. (2012) Rnd3/RhoE is down-regulated in hepatocellular carcinoma and controls cellular invasion. Hepatology, 55: 1766-75. PubMed: 22234932.
12. Belgiovine C, Frapolli R, Bonezzi K, Chiodi I, Favero F et al. (2010) Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells. PLOS ONE 5: e14154. doi:10.1371/journal.pone.0014154. PubMed: 21209796.
13. Zhou J, Li K, Gu Y, Feng B, Ren G et al. (2011) Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia. Biochem Biophys Res Commun 415: 348-354. doi:10.1016/j.bbrc.2011.10.065. PubMed: 22037464.
14. Ren G, Tian Q, An Y, Feng B, Lu Y et al. (2012) Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K. Mol Cancer 11: 67. doi:10.1186/1476-4598-11-67. PubMed: 22974233.
15. Jin H, Pan Y, He L, Zhai H, Li X et al. (2007) p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer. Mol Cancer Res 5: 423-433. doi:10.1158/1541-7786.MCR-06-0407. PubMed: 17510309. (Pubitemid 46903951)
16. Song J, Xie H, Lian Z, Yang G, Du R et al. (2006) Enhanced cell survival of gastric cancer cells by a novel gene URG4. Neoplasia 8: 995-1002. doi:10.1593/neo.06592. PubMed: 17217616.
17. Tie J, Pan Y, Zhao L, Wu K, Liu J et al. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLOS Genet 6: e1000879. PubMed: 20300657.
18. Zhang F, Ren G, Lu Y, Jin B, Wang J et al. (2009) Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: a novel cancer biomarker. Cancer Lett 274: 250-258. doi:10.1016/j.canlet.2008.09.031. PubMed: 18986759.
19. Liu N, Zhang G, Bi F, Pan Y, Xue Y et al. (2007) RhoC is essential for the metastasis of gastric cancer. J Mol Med (Berl) 85: 1149-1156. doi:10.1007/s00109-007-0217-y. PubMed: 17549441. (Pubitemid 47476732)
20. Ishida-Takagishi M, Enomoto A, Asai N, Ushida K, Watanabe T et al. (2012) The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility. Nat Commun 3: 859. doi:10.1038/ncomms1861. PubMed: 22643886.
21. Albini A, Benelli R (2007) The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc 2: 504-511. doi:10.1038/nprot.2006.466. PubMed: 17406614. (Pubitemid 47040014)
22. Pan Y, Zhao L, Liang J, Liu J, Shi Y et al. (2006) Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 20: 1886-1888. doi:10.1096/fj.06-6138fje. PubMed: 16877520.
23. Teicher BA, Fricker SP (2010) CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16: 2927-2931. doi:10.1158/1078-0432.CCR-09-2329. PubMed: 20484021.
24. Li K, Lu Y, Liang J, Luo G, Ren G et al. (2009) RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem Biophys Res Commun 379: 212-216. doi:10.1016/j.bbrc.2008.12.044. PubMed: 19101510.
25. Grise F, Sena S, Bidaud-Meynard A, Baud J, Hiriart JB et al. (2012) Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion. Hepatology 55: 1766-1775. doi:10.1002/hep.25568. PubMed: 22234932.
26. Riento K, Ridley AJ (2006) Inhibition of ROCK by RhoE. Methods Enzymol 406: 533-541. doi:10.1016/S0076-6879(06)06041-1. PubMed: 16472685. (Pubitemid 43207466)
27. Overall CM, López-Otín C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2: 657-672. doi:10.1038/nrc884. PubMed: 12209155. (Pubitemid 37328917)
28. Fukuda A, Wang SC, Morris JP 4th, Folias AE, Liou A et al. (2011) Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19: 441-455. doi:10.1016/j.ccr.2011.03.002. PubMed: 21481787.
29. Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: 1761-1767. doi:10.1182/blood-2005-08-3182. PubMed: 16269611. (Pubitemid 43289351)